CD4 and B-cell chronic lymphocytic leukemia: However, the preliminary observation that subjects with higher numbers of CLL-exclusive HLA class II-presented peptides experienced fewer relapses is a first hint for the importance of CD4+ T cell responses and warrants further analysis in a larger cohort of CLL patients.